Answers are grounded in this paper and cite their sources.
OBJECTIVE: To evaluate healthcare access barriers and their cumulative association with clinical and economic outcomes among Brazilians with diabetes, focusing on the primary care context and health inequalities. MATERIALS AND METHODS: A weighted survey (n = 1843) was conducted in 2024 using a structured questionnaire. The sample was weighted to match the Brazilian National Health Survey, ensuring representativeness of public health system users. A cumulative barrier score (0-8) was analyzed using Poisson regression adjusted for sociodemographic and clinical variables. RESULTS: The primary barriers identified were difficulty scheduling appointments (47.4%), medication unavailability (42.6%), and lack of supplies (39.4%). The mean barrier score was 4.13 (standard deviation 2.80). A consistent dose-response pattern showed that a higher cumulative barrier burden was associated with increased emergency department visits, higher out-of-pocket expenditures, and a greater prevalence of chronic complications (adjusted prevalence ratio 1.05 per additional barrier; 95% confidence interval 1.04-1.07; p < 0.001). These impacts were more pronounced among low-income individuals and those with type 1 diabetes. CONCLUSION: Healthcare access barriers are highly prevalent in Brazil and are cumulatively associated with adverse clinical and economic outcomes. This cumulative burden serves as a pragmatic marker for identifying high-risk individuals and informs public health strategies to reduce health inequalities and improve care delivery in primary care settings.
No takes yet. Share an insight, caveat, or question.
Siqueira et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: